Reducing risk of Alzheimer’s Disease in individuals with Down syndrome

The Vanderbilt Kennedy Center researchers in this episode are studying the connection of Down syndrome and Alzheimer’s Disease. The Trial-Ready Cohort-Down Syndrome Study will identify individuals over age 35 with Down syndrome, obtain information about how they are functioning, and evaluate their brain activity and structure. This work will identify individuals with Down syndrome who may be eligible for a future medication study with the goal of reducing their risk for the development of Alzheimer’s disease.

VKC Researcher: Paul Newhouse, M.D., Jim Turner Professor of Cognitive Disorders; Professor of Psychiatry & Behavioral Sciences, Pharmacology, and Medicine; Director, Vanderbilt Center for Cognitive Medicine

Interviewer: Elise McMillan, J.D., Co-Director, Vanderbilt Kennedy Center for Excellence in Developmental Disabilities; Director of Community Engagement and Public Policy; and Senior Lecturer in Psychiatry & Behavioral Sciences